Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32979 | 100 | 28.8 | 58% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1502 | 7002 | BARRETTS ESOPHAGUS//BARRETTS OESOPHAGUS//ESOPHAGEAL ADENOCARCINOMA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LMTK3 | Author keyword | 6 | 100% | 4% | 4 |
| 2 | RB1CC1 | Author keyword | 3 | 50% | 4% | 4 |
| 3 | RB1 INDUCIBLE COILED COIL 1 | Author keyword | 3 | 60% | 3% | 3 |
| 4 | UNDER ASCERTAINMENT | Author keyword | 2 | 44% | 4% | 4 |
| 5 | BASIC SCI HLTH NURSING | Address | 1 | 31% | 4% | 4 |
| 6 | LEMUR TYROSINE KINASE 3 LMTK3 | Author keyword | 1 | 100% | 2% | 2 |
| 7 | ASIAN REG OFF CANC CONTROL | Address | 1 | 50% | 1% | 1 |
| 8 | BAYESIAN AGE PERIOD COHORT MODEL | Author keyword | 1 | 50% | 1% | 1 |
| 9 | CANC OURCE EDUC | Address | 1 | 50% | 1% | 1 |
| 10 | CANCER CHARACTERISTICS | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LMTK3 | 6 | 100% | 4% | 4 | Search LMTK3 | Search LMTK3 |
| 2 | RB1CC1 | 3 | 50% | 4% | 4 | Search RB1CC1 | Search RB1CC1 |
| 3 | RB1 INDUCIBLE COILED COIL 1 | 3 | 60% | 3% | 3 | Search RB1+INDUCIBLE+COILED+COIL+1 | Search RB1+INDUCIBLE+COILED+COIL+1 |
| 4 | UNDER ASCERTAINMENT | 2 | 44% | 4% | 4 | Search UNDER+ASCERTAINMENT | Search UNDER+ASCERTAINMENT |
| 5 | LEMUR TYROSINE KINASE 3 LMTK3 | 1 | 100% | 2% | 2 | Search LEMUR+TYROSINE+KINASE+3+LMTK3 | Search LEMUR+TYROSINE+KINASE+3+LMTK3 |
| 6 | BAYESIAN AGE PERIOD COHORT MODEL | 1 | 50% | 1% | 1 | Search BAYESIAN+AGE+PERIOD+COHORT+MODEL | Search BAYESIAN+AGE+PERIOD+COHORT+MODEL |
| 7 | CANCER CHARACTERISTICS | 1 | 50% | 1% | 1 | Search CANCER+CHARACTERISTICS | Search CANCER+CHARACTERISTICS |
| 8 | RB1CC1 RB1 INDUCIBLE COILED COIL 1 | 1 | 50% | 1% | 1 | Search RB1CC1+RB1+INDUCIBLE+COILED+COIL+1 | Search RB1CC1+RB1+INDUCIBLE+COILED+COIL+1 |
| 9 | WORLD DATA | 1 | 50% | 1% | 1 | Search WORLD+DATA | Search WORLD+DATA |
| 10 | CENTRAL ASIAN COUNTRIES | 0 | 33% | 1% | 1 | Search CENTRAL+ASIAN+COUNTRIES | Search CENTRAL+ASIAN+COUNTRIES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FIP200 | 3 | 33% | 8% | 8 |
| 2 | LMTK3 | 2 | 67% | 2% | 2 |
| 3 | NUCLEAR TESTING SITE | 2 | 67% | 2% | 2 |
| 4 | RB1CC1 | 1 | 50% | 2% | 2 |
| 5 | ANTIESTROGENS TAMOXIFEN | 0 | 25% | 1% | 1 |
| 6 | RECEPTOR AGONIST CISAPRIDE | 0 | 25% | 1% | 1 |
| 7 | TYROSINE KINASE ROR1 | 0 | 25% | 1% | 1 |
| 8 | PRESSURE MEASURING DEVICE | 0 | 20% | 1% | 1 |
| 9 | RHABDOID TUMOR CELLS | 0 | 17% | 1% | 1 |
| 10 | HOMEOSTATIC SWITCH | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| FIP200, a key signaling node to coordinately regulate various cellular processes | 2008 | 23 | 57 | 19% |
| Chronic Disease Prevention Research in Central Asia, the Urals, Siberia and Mongolia - Past, Present and Future | 2009 | 4 | 45 | 42% |
| Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer | 2011 | 1 | 7 | 43% |
| The obesity epidemic, metabolic syndrome and future prevention strategies | 2004 | 257 | 10 | 10% |
| Cancer Epidemiology and Control in North-Western and Central Asia - Past, Present and Future | 2010 | 30 | 138 | 7% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BASIC SCI HLTH NURSING | 1 | 31% | 4.0% | 4 |
| 2 | ASIAN REG OFF CANC CONTROL | 1 | 50% | 1.0% | 1 |
| 3 | CANC OURCE EDUC | 1 | 50% | 1.0% | 1 |
| 4 | IOTF | 1 | 50% | 1.0% | 1 |
| 5 | U 579 | 0 | 33% | 1.0% | 1 |
| 6 | BIOMED SCI ICBIM | 0 | 20% | 1.0% | 1 |
| 7 | ONCOL 4 | 0 | 17% | 1.0% | 1 |
| 8 | CLIN PREVENT CARDIOL | 0 | 14% | 1.0% | 1 |
| 9 | CARDIO P DIS EPIDEMIOL PREVENT | 0 | 100% | 1.0% | 1 |
| 10 | CLIN GEN VIS TRANSPLANTAT SURG | 0 | 100% | 1.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000100009 | HIGH INCIDENCE AREA//HEBEI TUMOR HOSP//GOLESTAN GASTROENTEROL HEPATOL |
| 2 | 0.0000075351 | RATS WITH VARIOUS BEHAVIORAL CHARACTERISTICS//INTERNAL LOCALIZATION//NEAR PATIENT ASSAY |
| 3 | 0.0000066893 | PADMA 28//TIBETAN MEDICINE//PADMA LAX |
| 4 | 0.0000059884 | AGE PERIOD COHORT MODELS//AGE PERIOD COHORT MODEL//INTRINSIC ESTIMATOR |
| 5 | 0.0000057524 | MICROPOPULATION//MICROPOPULATION MODEL//EXPONENTIAL RISK AVOIDANCE MODELS |
| 6 | 0.0000056213 | CDK2AP1//DOC 1//P12CDK2 AP1 |
| 7 | 0.0000047392 | AUTOPHAGY//BECLIN 1//LC3 |
| 8 | 0.0000047341 | TURKISH SOC CARDIOL//EXECUTIVE STRESS//MINNESOTA CODING |
| 9 | 0.0000046524 | ARTERIOLOSCLEROSIS//NEPHROSCLEROSIS//DECOMPENSATED BENIGN NEPHROSCLEROSIS |
| 10 | 0.0000043221 | PANDER//FAM3B//PANCREATIC DERIVED FACTOR |